Correlation of polymorphous variants (ApaI, TagI, BsmI) of the VDR receptor gene with the vitamin D level and liver fibrosis in children with autoimmune hepatitis
DOI:
https://doi.org/10.14739/2310-1210.2019.4.173196Keywords:
children, autoimmune hepatitis, fibrosis, vitamin D, genetic polymorphism, VDR geneAbstract
The aim. To study the correlation of the frequency distribution of alleles, genotypes and their combinations for the allelic variants of ApaI, TagI, BsmI of the Vitamin D receptor gene (VDR) with the vitamin D levels and the stage of fibrosis in children with autoimmune hepatitis.
Materials and methods. 51 children with autoimmune hepatitis were examined between 2016 and 2018. In all children, the diagnosis was confirmed in accordance with the International Guidelines for the study of liver diseases (European Association for the Study of Liver (EASL) Clinical Practice Guidelines: Autoimmune Hepatitis, 2015). In the examined children, the elastography of the liver parenchyma was performed by the shear wave method. Needle biopsy of the liver with histological examination of the specimens was performed in 42 children. The disease activity was determined using the histological activity index (HAI) by Knodell based on the results of a morphological study of the liver biopsy and biochemical parameters. The stage of the disease was evaluated by the histological index of fibrosis using the METAVIR scoring system and semi-quantitatively using the share wave elastography of liver parenchyma. A level of 25(OH)D was determined in the blood serum. The determination of the ApaI, TagI, BsmI polymorphic loci of vitamin D receptor (VDR) was carried out using the molecular-genetic method. The association of polymorphic variants of the VDR gene with the level of vitamin D and the stage of liver fibrosis in children with autoimmune hepatitis has been evaluated.
Results. 72.0 % of the examined children had advanced severe liver fibrosis (F3-4 by the METAVIR score), among them 34.0 % of children had signs of liver cirrhosis. Children with advanced severe fibrosis (F3–4 by the METAVIR score) had the CC genotype of the polymorphic version of the TagI of the VDR gene significantly more often (χ2 = 3.953; P < 0.05), and the genotype AA/CC/AA according to the investigated allelic variants of the VDR gene (χ2 = 3.953; P < 0.05). In 72.5 % of the examined children, there was a deficiency of vitamin D. In children with severe fibrosis (F3–4 by the METAVIR score) vitamin D deficiency was significantly more frequent as compared to children with less severe fibrosis (F1–2 by the METAVIR score) (χ2 = 5,207; P = 0.023). The genotype GA of the BsmI polymorphic variant was associated with a decrease in serum vitamin D levels (P < 0.05). At the AC/TC/GA combination of the ApaI, TagI and BsmI allelic variants of the VDR gene, vitamin D deficiency was registered significantly more frequently (P < 0.05).
Conclusions. The level of vitamin D in children with autoimmune hepatitis was dependent on the stage of fibrosis. Children with severe fibrosis had a genetically determined vitamin D deficiency significantly more often. Vitamin D deficiency was associated with the CC genotype presence of the TagI polymorphic variant of the VDR gene in patients as well as the GA genotype of the BsmI polymorphic variant and the AC/TC/GA genotype of the three allelic variants of the gene studied.
References
Luong, K. V., & Nguyen, L. T. (2013). The Role of Vitamin D in Autoimmune Hepatitis. J ClinMedRes. 5(6), 407–415. doi: 10.4021/jocmr1505w
Efe, C., Kav, T., Aydin, C., Cengiz, M., Imga, N. N., Purnak, T., et al. (2014). Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis Article in Digestive Diseases and Sciences. DisDisSci, 59(12), 3035–42. doi: 10.1007/s10620-014-3267-3
Eltayeb, A. A., Abdou, M. A., Abdel-aal, A. M., & Othman, M. H. (2015). Vitamin D status and viral response to the rapy in hepatitis C infected children. World J Gastroenterol., 21(4), 1284–1291. doi: 10.3748/wjg.v21.i4.1284
Kamen, D L, & Tangpricha, V. (2010). Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med., 88, 441–450. doi: 10.1007/s00109-010-0590-9
Iruzubieta, P., Terán, Á., Crespo, J., & Fábrega, E. (2014).Vitamin D deficiency in chronic liver disease. World J Hepatol., 6(12), 901–915. doi: 10.4254/wjh.v6.i12.901
Povorozniuk, V. V., & Pludovski, P. (2014). Defitsyt ta nedostatnist vitaminu D: epidemiolohiia, diahnostyka, profilaktyka ta likuvannia [Vitamin D-deficiency and insufficiency: epidemiology, diagnostics, prevention and treatment]. Doneсk. [in Ukrainian].
Kitson, M. T., & Roberts, S. K. (2012). D-livering the message: The importance of vitamin D status in chronic liver disease. J Hepatol., 57(4), 897–909. doi: 10.1016/j.jhep.2012.04.033
Mora, J. R, Iwata, M., von Andrian, U. H. (2008). Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol., 8(9), 685–98. doi: 10.1038/nri2378
Kamen, D. L., & Tangpricha, V. (2010). Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl), 88(5), 441–450. doi: 10.1007/s00109-010-0590-9
Agmon-Levin, N., Theodor, E., Segal, R. M., & Shoenfeld, Y. (2013). Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol, 45, 256–66, doi: 10.1007/s12016-012-8342-y
Kamen, D. L, & Tangpricha, V. (2010). Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med., 88(5), 441–50. doi: 10.1007/s00109-010-0590-9
Malham, M., Jorgensen, S. P., Ott, P., Agnholt, J., Vilstrup, H., Borre, M., & Dahlerup, J. F. (2011). Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol., 17(7), 922–925. doi: 10.3748/wjg.v17.i7.922
Yakovleva, O. A., Nikolova, O. M., Doroshkevich, I. A., & Shcherbenyuk, N. V. (2017). Geneticheskij polimorfizm receptora vitamina D opredeljaet ego metabolizm i e'ffektivnost' [Genetic polymorphism of vitamin D receptor determines its metabolism and efficiency]. Bol'. Sustavy. Pozvonochnik., 7(2), 73–78. doi: 10.22141/2224-1507.7.2.2017.108699
Peterlik, M., & Cross, H. S. (2009). Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. European Journal of Clinical Nutrition., 63, 1377–1386. doi: 10.1038/ejcn.2009.105
Arteh, J., Narra, S., & Nair, S (2010). Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci., 55(9), 2624–8. doi: 10.1007/s10620-009-1069-9
Fan, L., Tu, X., Zhu, Y., Zhou, L., Pfeiffer, T., Feltens, R., et al. (2005) Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol., 20(2), 249–55. doi: 10.1111/j.1440-1746.2005.03532.x
Luong, K. V., & Nguyen, L. T. (2013). The Role of Vitamin D in Autoimmune Hepatitis. J Clin Med Res., 5(6), 407–415. doi: 10.4021/jocmr1505w
Altieri, B., Muscogiuri, G., Barrea, L., Mathieu, Ch., Vallone, C. V., Mascitelli, L., et al. (2017). Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord., 18(3), 335–346. doi: 10.1007/s11154-016-9405-9
Konstantakis, C., Tselekouni, P., Kalafateli, M., && Triantos, C. (2016). Vitamin D deficiency in patients with liver cirrhosis. Ann Gastroenterol., 29(3), 297–306. doi: 10.20524/aog.2016.0037
Kempińska-Podhorecka, A., Wunsch, E., Jarowicz, T., Raszeja-Wyszomirska, J., Loniewska, B., Kaczmarczyk, M., et al. (2012). Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population. Gastroenterology Research and Practice, 2012, 408723. doi: 10.1155/2012/408723
Vogel, A., Strassburg, C. P., & Manns, M. (2002). Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology., 35(1), 126–31. doi: 10.1053/jhep.2002.30084
Tanaka, A., Nezu, S., Uegaki, S., Kikuchi, K., Shibuya, A., Miyakawa, H., et al. (2009). Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol., 50(6), 1202–9. doi: 10.1016/j.jhep.2009.01.015
Adorini, L. (2009). Vitamin D receptor polymorphisms in primary biliary cirrhosis: Afunctional connection? Journal of Hepatology, 50(6), 1071–1073. doi: https://doi.org/10.1016/j.jhep.2009.03.005
Czaja, A. J., Carpenter, H. A., & Moore, S. B. (2008). HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients. Dig Dis Sci., 53(2), 522–528. doi: 10.1007/s10620-007-9859-4
Ferri Liu, P. M., de Miranda, D. M., Fagundes, E. D., Ferreira, A. R., & Simões e Silva, A. C. (2013). Autoimmune hepatitis in childhood: The role of genetic and immune factors. World J Gastroenterol., 19(28), 4455–4463. doi: 10.3748/wjg.v19.i28.4455
Verma, S., Torbenson, M., & Thuluvath, P. J. (2007). The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology, 46(6), 1828–1835. doi: 10.1002/hep.21884
Radhakrishnan, K. R., Alkhouri, N., Wolrley, S., Arrigain, S., Hupertz, V., Kay, M., et al. (2010). Autoimmune hepatitis in children–impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis., 42(10), 724–728. doi: 10.1016/j.dld.2010.01.002
European Association for TheStudy of the Liver (2015). EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology, 63(4), 971–1004. doi: 10.1016/j.jhep.2015.06.030
Rasheed, H., Hegazy, R. A., Gawdat, H. I., Mehaney, D. A., Kamel, M. M., Fawzy, M. M., et al. (2016) Serum vitamin D and vitamin D receptor gene polymorphism in mycosis fungoides patients: a case control study. PLoS One., 11(6), e0158014. doi:10.1371/journal.pone.0158014
Obukhova, O. A. (2014). Rozpodil polimorfizmiv VDR-hena v ukrainskoho naselennia ta poshuk yikh zviazku iz rozvytkom aterotrombotychnoho insult (Avtoref. dis…kand. biol. nauk). [The distribution of polymorphisms in the VDR-gene in Ukrainian population and search of their association with the development of atherothrombotic stroke. Dr. biol. sci. diss.]. Kyiv. [in Ukrainian].
Berzigotti, A., & Castera L. (2013). Update on ultrasound imaging of liver fibrosis. Journal of Hepatology., 59, 180–182. doi.org/10.1016/j.jhep.2012.12.028
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
